NDC 65162-749 – Rivastigmine
Rivastigmine 13.3 mg/24h · Patch · Transdermal
Product NDC65162-749
Product details
- Brand name
- Rivastigmine
- Generic name
- Rivastigmine
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- Patch
- Route
- Transdermal
- Marketing category
- ANDA · ANDA207308
- Marketed since
- June 30, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor
Active ingredients
- Rivastigmine 13.3 mg/24h
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 65162-749-34 | 30 PATCH in 1 CARTON (65162-749-34) / 24 h in 1 PATCH | Jun 30, 2015 |
Other Rivastigmine products
- 65162-825 Rivastigmine 4.6 mg/24h · Patch · Amneal Pharmaceuticals LLC
- 65162-826 Rivastigmine 9.5 mg/24h · Patch · Amneal Pharmaceuticals LLC
- 0378-9070 Rivastigmine 4.6 mg/24h · Patch · Mylan Pharmaceuticals Inc.
- 0378-9071 Rivastigmine 9.5 mg/24h · Patch · Mylan Pharmaceuticals Inc.
- 0378-9072 Rivastigmine 13.3 mg/24h · Patch · Mylan Pharmaceuticals Inc.
- 16714-116 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Northstar Rx LLC.
- 16714-117 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Northstar Rx LLC.
- 0781-7304 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Sandoz Inc
- 0781-7309 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Sandoz Inc
- 0781-7313 Rivastigmine 13.3 mg/24h · Patch, Extended Release · Sandoz Inc
- 70771-1949 Rivastigmine 4.6 mg/24h · Patch, Extended Release · Zydus Lifesciences Limited
- 70771-1950 Rivastigmine 9.5 mg/24h · Patch, Extended Release · Zydus Lifesciences Limited